Page last updated: 2024-12-05

benzotrifluoride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Benzotrifluoride, also known as trifluoromethylbenzene, is an organic compound with the formula C6H5CF3. It is a colorless liquid with a characteristic aromatic odor. Benzotrifluoride is an important intermediate in the synthesis of various pharmaceuticals, agrochemicals, and other fine chemicals. Its synthesis is typically achieved through the reaction of benzene with trifluoromethyl bromide in the presence of a Lewis acid catalyst. Benzotrifluoride exhibits a wide range of biological and pharmacological activities, including antifungal, antibacterial, and anticancer properties. Its high lipophilicity and electron-withdrawing nature contribute to its ability to penetrate cell membranes and interact with biological targets. Benzotrifluoride is also used as a solvent and as a starting material for the production of other valuable compounds. The compound is often studied for its potential applications in various industries, including medicine, agriculture, and materials science.'

alpha,alpha,alpha-trifluorotoluene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(trifluoromethyl)benzene : A fluorohydrocarbon that is fluoroform in which the hydrogen is substituted by a phenyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7368
CHEMBL ID15897
CHEBI ID36810
SCHEMBL ID8692
MeSH IDM0130378

Synonyms (78)

Synonym
.alpha.,.alpha.-trifluorotoluene
benzenyl fluoride
benzylidyne fluoride
nsc-8038
.omega.-trifluorotoluene
usaf ma-16
phenylfluoroform
98-08-8
wln: fxffr
(trifluoromethyl)benzene
benzotrifluoride
benzene, (trifluoromethyl)-
nsc8038
toluene, .alpha.,.alpha.,.alpha.-trifluoro-
omega-trifluorotoluene
c6h5cf3
alpha,alpha,alpha-trifluorotoluene
cf3ph
trifluoromethylbenzene
phcf3
CHEBI:36810 ,
trifluoromethyl-benzene
inchi=1/c7h5f3/c8-7(9,10)6-4-2-1-3-5-6/h1-5
NCGC00091831-01
hsdb 2077
nsc 8038
ccris 2808
un2338
brn 1906908
toluene trifluoride
toluene, alpha,alpha,alpha-trifluoro-
ai3-14870
einecs 202-635-0
alpha,alpha,alpha-trifluorotoluene, anhydrous, >=99%
CHEMBL15897
T0439
AKOS000120183
A845805
NCGC00091831-02
tox21_200954
cas-98-08-8
NCGC00258507-01
dtxsid2024589 ,
dtxcid404589
a,a,a-trifluorotoluene
4-05-00-00802 (beilstein handbook reference)
49r6421k89 ,
unii-49r6421k89
benzotrifluoride [un2338] [flammable liquid]
FT-0622737
AM62156
toluene, .alpha.-trifluoro-
trifluoro(phenyl)methane
un-2338
.alpha.,.alpha.,.alpha.-trifluorotoluene
benzotrifluoride [mi]
(1,1',1''-trifluoromethyl)benzene
1',1',1'-trifluorotoluene
SCHEMBL8692
trifluortoluol
4-trifluoromethylbenzene
trifluoromethyl benzene
alpha,alpha.alpha-trifluorotoluene
trifluoro methyl benzene
trifluoro-toluene
alpha, alpha, alpha-trifluorotoluene
un 2338
STL453680
F0001-2313
mfcd00000372
alpha,alpha,alpha-trifluorotoluene, >=99%
alpha,alpha,alpha-trifluorotoluene 2000 microg/ml in methanol
alpha,alpha,alpha-trifluorotoluene-d5
Q409755
PS-11886
alpha , alpha , alpha -trifluorotoluene
EN300-19414
Z104473746
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
solventA liquid that can dissolve other substances (solutes) without any change in their chemical composition.
environmental contaminantAny minor or unwanted substance introduced into the environment that can have undesired effects.
NMR chemical shift reference compoundAny compound that produces a peak used to reference an NMR spectrum during data pre-processing.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
fluorohydrocarbonA compound derived from a hydrocarbon by replacing one or more hydrogen atoms with fluorine atoms.
(trifluoromethyl)benzenesAn organofluorine compound that is (trifluoromethyl)benzene and derivatives arising from substitution of one or more of the phenyl hydrogens.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency75.00640.000714.592883.7951AID1259369
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency25.11890.011212.4002100.0000AID1030
thyroid stimulating hormone receptorHomo sapiens (human)Potency6.30960.001318.074339.8107AID926; AID938
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency50.11870.001024.504861.6448AID588535
aryl hydrocarbon receptorHomo sapiens (human)Potency66.84950.000723.06741,258.9301AID743085
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID19262Aqueous solubility2000Bioorganic & medicinal chemistry letters, Jun-05, Volume: 10, Issue:11
Prediction of drug solubility from Monte Carlo simulations.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (11.11)18.7374
1990's1 (3.70)18.2507
2000's10 (37.04)29.6817
2010's10 (37.04)24.3611
2020's3 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 56.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index56.27 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index4.89 (4.65)
Search Engine Demand Index87.76 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (56.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]